Floatz logo

RAMIFENTANYL

Paravertebral Block

University of RijekaSmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

7 Active assets in the Paravertebral Block cohort.

Asset / SponsorPhaseRating
LIDOCAINE
Tanta University
Phase 4BB
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Tanta University
Phase 4BB
L-Bupivacaine
University of Rijeka
Phase 4BB
Desflurane
University of Rijeka
N/AD
PROPOFOL
University of Rijeka
N/AD
SUFENTANIL CITRATE
University of Rijeka
N/AD
CISATRACURIUM ION
University of Rijeka
N/AD

Same molecule, other indications

RAMIFENTANYL is also rated in:

morbid obesityDormant
BBB
Indicative ·
73 / 100
View asset →
cardiovascular disorderDormant
BBB
Indicative ·
73 / 100
View asset →
Anesthesia, GeneralDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →